Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 98% | 5701.46 | 452 / 459 | 99% | 104.50 | 1109 / 1118 |
uterus | 100% | 4475.41 | 170 / 170 | 91% | 59.23 | 418 / 459 |
skin | 97% | 4943.85 | 1748 / 1809 | 94% | 68.94 | 444 / 472 |
lung | 100% | 4448.01 | 577 / 578 | 89% | 35.88 | 1030 / 1155 |
thymus | 99% | 2987.59 | 647 / 653 | 89% | 31.85 | 536 / 605 |
esophagus | 88% | 2561.04 | 1272 / 1445 | 93% | 35.71 | 170 / 183 |
kidney | 90% | 2115.06 | 80 / 89 | 88% | 66.64 | 793 / 901 |
pancreas | 78% | 1077.38 | 257 / 328 | 97% | 58.58 | 172 / 178 |
ovary | 98% | 2832.31 | 177 / 180 | 66% | 21.20 | 284 / 430 |
liver | 91% | 1734.19 | 206 / 226 | 69% | 18.90 | 282 / 406 |
bladder | 81% | 2535.05 | 17 / 21 | 78% | 38.91 | 393 / 504 |
intestine | 89% | 1739.11 | 855 / 966 | 69% | 21.39 | 363 / 527 |
prostate | 99% | 2841.32 | 243 / 245 | 54% | 10.40 | 269 / 502 |
stomach | 64% | 1027.96 | 229 / 359 | 66% | 20.16 | 190 / 286 |
brain | 70% | 3307.76 | 1857 / 2642 | 58% | 16.57 | 409 / 705 |
adrenal gland | 50% | 883.66 | 128 / 258 | 72% | 22.28 | 166 / 230 |
spleen | 100% | 12435.66 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.65 | 1 / 1 |
heart | 99% | 2878.58 | 852 / 861 | 0% | 0 | 0 / 0 |
adipose | 97% | 3318.51 | 1168 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 37.55 | 40 / 45 |
blood vessel | 85% | 2236.55 | 1134 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 45% | 10.13 | 36 / 80 |
muscle | 31% | 371.58 | 246 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.87 | 2 / 29 |
peripheral blood | 1% | 8.39 | 9 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0007052 | Biological process | mitotic spindle organization |
GO_0002862 | Biological process | negative regulation of inflammatory response to antigenic stimulus |
GO_0060292 | Biological process | long-term synaptic depression |
GO_0046599 | Biological process | regulation of centriole replication |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0090050 | Biological process | positive regulation of cell migration involved in sprouting angiogenesis |
GO_0032486 | Biological process | Rap protein signal transduction |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0006977 | Biological process | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
GO_0071866 | Biological process | negative regulation of apoptotic process in bone marrow cell |
GO_0007613 | Biological process | memory |
GO_0006468 | Biological process | protein phosphorylation |
GO_2000773 | Biological process | negative regulation of cellular senescence |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0000922 | Cellular component | spindle pole |
GO_0005813 | Cellular component | centrosome |
GO_0000776 | Cellular component | kinetochore |
GO_0005814 | Cellular component | centriole |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0043008 | Molecular function | ATP-dependent protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PLK2 |
Protein name | Serine/threonine-protein kinase PLK (EC 2.7.11.21) (Polo-like kinase) Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) |
Synonyms | SNK |
Description | FUNCTION: Tumor suppressor serine/threonine-protein kinase involved in synaptic plasticity, centriole duplication and G1/S phase transition. Polo-like kinases act by binding and phosphorylating proteins that are already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates CENPJ, NPM1, RAPGEF2, RASGRF1, SNCA, SIPA1L1 and SYNGAP1. Plays a key role in synaptic plasticity and memory by regulating the Ras and Rap protein signaling: required for overactivity-dependent spine remodeling by phosphorylating the Ras activator RASGRF1 and the Rap inhibitor SIPA1L1 leading to their degradation by the proteasome. Conversely, phosphorylates the Rap activator RAPGEF2 and the Ras inhibitor SYNGAP1, promoting their activity. Also regulates synaptic plasticity independently of kinase activity, via its interaction with NSF that disrupts the interaction between NSF and the GRIA2 subunit of AMPARs, leading to a rapid rundown of AMPAR-mediated current that occludes long term depression. Required for procentriole formation and centriole duplication by phosphorylating CENPJ and NPM1, respectively. Its induction by p53/TP53 suggests that it may participate in the mitotic checkpoint following stress. . |
Accessions | ENST00000617412.1 Q9NYY3 ENST00000274289.8 A0A087WUH9 |